Sanjeeva Dissanayake

Intrathecal Ziconotide for Severe Chronic Pain: Safety and Tolerability Results of an Open-Label, Long-Term Trial

Mark S. Wallace, Richard Rauck, Robert B. Fisher et al. · Anesthesia & Analgesia · 2008 · 108 citations

Medicine, Pharmacology, Pharmacotherapy +17

Equivalence Considerations for Orally Inhaled Products for Local Action—ISAM/IPAC-RS European Workshop Report

Carole Evans, David Cipolla, Tim Chesworth et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2012 · 56 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Fluticasone/Formoterol Combination Therapy versus Budesonide/Formoterol for the Treatment of Asthma: A Randomized, Controlled, Non-Inferiority Trial of Efficacy and Safety

Anna Bodzenta­‐Łukaszyk, Roland Buhl, Beatrix Bálint et al. · Journal of Asthma · 2012 · 53 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Continuous Intrathecal Infusion of Ziconotide for Treatment of Chronic Malignant and Nonmalignant Pain Over 12 Months: A Prospective, Open-label Study

David Ellis, Sanjeeva Dissanayake, Dawn McGuire et al. · Neuromodulation Technology at the Neural Interface · 2008 · 52 citations

Medicine, Oncology, Pharmacotherapy +12

Superiority of fluticasone propionate/formoterol fumarate versus fluticasone propionate alone in patients with moderate-to-severe asthma: a randomised controlled trial

Tetyana Pertseva, Sanjeeva Dissanayake, Kirsten Kaiser · Current Medical Research and Opinion · 2013 · 27 citations

Pharmacy, Pharmacology, Pharmacotherapy +17